Lamotrigine controlled-release

Drug Profile

Lamotrigine controlled-release

Alternative Names: Lamictal XR; Lamotrigine CR; Lamotrigine ER; Lamotrigine extended-release

Latest Information Update: 10 Sep 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator GlaxoSmithKline
  • Class Antiepileptic drugs; Small molecules; Triazines
  • Mechanism of Action Sodium channel antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Marketed Partial epilepsies; Tonic-clonic epilepsy

Most Recent Events

  • 14 Jun 2016 Biomarkers information updated
  • 08 Jan 2013 Generic equivalent available in USA
  • 25 Apr 2011 Launched for Partial seizures (conversion to monotherapy in patients taking one anti-epileptic drug) in USA (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top